2020 Virtual Conference Agenda

CLINICAL

PRACTICE OPERATIONS

All Sessions take place Eastern Standard Time (EST)

THURSDAY, APRIL 23, 2020
8:30 - 8:50 AM	Conference Opening Day One: Welcome From the Co-Chairs Robert Baird, Jr., RN, MSA, National Cancer Treatment Alliance Stephen (Fred) Divers, MD, Medical Oncologist, Hematologist, Genesis Cancer Center David Eagle, MD, Medical Oncologist, Hematologist, Novant Lake Norman Oncology Debra Patt, MD, MPH, MBA, Vice President, Medical Oncologist, Hematologist, Texas Oncology Jeffrey Patton, MD, Chief Executive Officer, Medical Oncologist, Tennessee Oncology Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders Jeff Vacirca, MD, FACP, Chief Executive Officer, Medical Oncologist, Hematologist, New York Cancer & Blood Specialists
8:50 - 9:30 AM	Top Community Oncology Issues Now & Looking Ahead Robert Braun, Corporate VP Operations & Integration, Regional Cancer Care Associates, LLC Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, Moderator Kathy Oubre, MS, Chief Operating Officer, Pontchartrain Cancer Center Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders
9:35 - 10:15 AM	Oncology Payment Reform: Updates on the OCM 1.0, COA OCM 2.0, & CMMI OCF Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, Moderator Kashyap Patel, MD, Chief Executive Officer, COA Payment Reform Co-Chair, Carolina Blood & Cancer Care Associates Lalan Wilfong, MD, Executive Vice President, Value Based Care & Quality Programs, COA Payment Reform Co-Chair, Texas Oncology
10:20 - 10:50 AM	Clinical Update: Skin Related Toxicities in Cancer Care Mario E. Lacouture, MD, Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
10:50 - 11:20 AM	Break to Visit the Virtual Exhibit Hall
11:20 - 12:00 PM	Cancer Versus COVID-19: What We Have Learned from the Crisis Sibel Blau, MD, Medical Director, Northwest Medical Specialties Steve D’Amato, BScPharm, Chief Executive Officer, New England Cancer Specialists Jeffrey Patton, MD, Chief Executive Officer, Medical Oncologist, Tennessee Oncology, Moderator Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants Anthony Scalzo, MD, President, Hematology Oncology Associates of CNY
12:05 - 12:35 PM	Clinical Update: The Latest on Metastatic Breast Cancer Neelima Denduluri, MD, Medical Oncologist, Virginia Cancer Specialists
12:40 - 1:10 PM	The Now & Future of Clinical Trials in the Community Oncology Setting Howard “Skip” Burris, III, MD, FACP, FASCO, President, Chief Medical Officer, Sarah Cannon Research Institute, American Society of Clinical Oncology
1:10 - 1:40 PM	Break to Visit the Virtual Exhibit Hall
1:40 - 2:20 PM	The Employer Perspective: Meeting Employee Needs While Controlling Cancer Care Costs Deborah Gan, Executive Director, Integrated Account Management, Strategic Insights, Merck Cheryl Larson, President, Chief Executive Officer, Midwest Business Group on Health Frederick Schnell, MD, Chief Medical Officer, Community Oncology Alliance, Moderator Thomas Sondergeld, HR Executive, Former VP of Global Benefits of Walgreens Boots Alliance, Self-Employed
2:25 - 2:55 PM	Stereotactic Radiation Combined With Immunotherapy in Metastatic Disease Anshu Jain, MD, Radiation Oncologist, Ashland Bellefonte Cancer Center
3:00 - 3:30 PM	Emerging Trends in Telehealth & Information Technology Nick Recker, President, Path Forward
3:35 - 4:05 PM	Gut Check: The Dynamics of the Gut Microbiome & Cancer Axel Grothey, MD, Medical Oncologist, West Cancer Center
4:10 - 4:40 PM	New Age of Running a Practice: Cyber Security & Compliance in Health Care John DiMaggio, Chief Executive Officer, Clinical Research, BlueOrange Compliance
FRIDAY, APRIL 24, 2020
8:30 - 8:50 AM	Conference Opening Day Two: Welcome From the Co-Chairs Robert Baird, Jr., RN, MSA, National Cancer Treatment Alliance Stephen (Fred) Divers, MD, Medical Oncologist, Hematologist, Genesis Cancer Center David Eagle, MD, Medical Oncologist, Hematologist, Novant Lake Norman Oncology Debra Patt, MD, MPH, MBA, Vice President, Medical Oncologist, Hematologist, Texas Oncology Jeffrey Patton, MD, Chief Executive Officer, Medical Oncologist, Tennessee Oncology Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders Jeff Vacirca, MD, FACP, Chief Executive Officer, Medical Oncologist, Hematologist, New York Cancer & Blood Specialists
8:55 - 9:25 AM	Spotlight on PBM Pricing Tricks Antonio Ciaccia, Chief Strategy Officer, 3 Axis Advisors
9:30 - 10:00 AM	The Exciting New World of Applied Informatics in Oncology Debra Patt, MD, MPH, MBA, Vice President, Medical Oncologist, Hematologist, Texas Oncology
10:00 - 10:30 AM	Break to Visit the Virtual Exhibit Hall
10:30 - 11:10 AM	Power & Potential of Genomic Profiling in Cancer: Stakeholder Panel Discussion Alan Balch, PhD, Chief Executive Officer, National Patient Advocate Foundation LuAnn Clothier, Patient Advocate Martin Dietrich, MD, PhD, Assistant Professor of Internal Medicine, University of Central Florida Jane Gibson, PhD, FACMG, Chair, Clinical Sciences Department, University of Central Florida College of Medicine Lee Schwartzberg, MD, FACP, Executive Director, West Cancer Center & Research Institute, Moderator Anthony “Nino” Sireci, MD, Vice President, Diagnostics Development & Medical Affairs, Loxo Oncology
11:15 - 11:55 AM	Legislative Update From Capitol Hill: Cancer Politics & Policy in Washington D.C. Christian G. Downs, JD, MHA, Executive Director, Association of Community Cancer Centers Ben Jones, Vice President, Government Relations, The US Oncology Network Deborah Kamin, RN, PhD, Vice President, Policy & Advocacy, American Society of Clinical Oncology Ali Murphy, Manager, Government Relations, Cardinal Health Ted Okon, MBA, Executive Director, Community Oncology Alliance, Moderator Brad Tallamy, Senior Director, Government Affairs, AmerisourceBergen
12:00 - 12:40 PM	PBM Legislation & Legal Issues at the National Level: The Experts Weigh In Michael Diaz, MD, Director of Patient Advocacy & Assistant Managing Physician, Florida Cancer Specialists & Research Institute, President, Community Oncology Alliance Jonathan E. Levitt, Esq., Founding Partner, Frier Levitt, LLC Jeff Mortier, Partner, Farragut Partners Ted Okon, MBA, Executive Director, Community Oncology Alliance, Moderator
12:40 - 1:10 PM	Break to Visit the Virtual Exhibit Hall
1:10 - 1:40 PM	Clinical Update: New Lung Cancer Treatments in the Age of Targeted & Immunotherapy Alexander Spira, MD, PhD, FACP, Director, Clinical Research, Virginia Cancer Specialists
1:45 - 2:25 PM	Operational & Clinical Considerations in a Medically Integrated Practice Ray Bailey, RPh, Pharmacy Director, Florida Cancer Specialists Gury K. Doshi, MD, Medical Director, Oral Oncolytics, Texas Oncology Jim Schwartz, RPh, Executive Director, Pharmacy Operations, Texas Oncology
2:30 - 3:00 PM	Real World Tumor & Plasma Genetic Testing Charu Aggarwal, MD, MPH, Leslye M. Heisler Assistant Professor of Medicine, Abramson Cancer Center, University of PA
3:05 - 3:45 PM	Improving Practice Workflows & Prior Authorization With Robotic Process Automation Bo Gamble , Director of Strategic Practice Initiatives, Community Oncology Alliance, Moderator Kathy Oubre, MS, Chief Operating Officer, Pontchartrain Cancer Center Syam Palakurthy, Chief Executive Officer, Co-Founder, SamaCare Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants
3:50 - 4:20 PM	Medical Cannabis: Clinical Considerations in Oncology Christine Roussel, PharmD, BCOP, Director of Pharmacy, Doylestown Hospital
4:25 - 4:55 PM	Conference Wrap-Up: Meeting Observations From the Co-Chairs & Audience Robert Baird, Jr., RN, MSA, National Cancer Treatment Alliance Stephen (Fred) Divers, MD, Medical Oncologist, Hematologist, Genesis Cancer Center David Eagle, MD, Medical Oncologist, Hematologist, Novant Lake Norman Oncology Debra Patt, MD, MPH, MBA, Vice President, Medical Oncologist, Hematologist, Texas Oncology Jeffrey Patton, MD, Chief Executive Officer, Medical Oncologist, Tennessee Oncology Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders Jeff Vacirca, MD, FACP, Chief Executive Officer, Medical Oncologist, Hematologist, New York Cancer & Blood Specialists